Barrier Methods of. Contraception

Similar documents
Birth Control Options

CONTRACEPTION TYPES CONTRACEPTION LARA SANDERS, RN CHAPTER 7 PAGES

Birth Control Methods

Achieving Independence

BARRIER METHODS (MALE AND FEMALE CONDOMS)

Condoms for the prevention of HIV and STI transmission

Chlamydia THE FACTS. How do people get Chlamydia?

Diseases that can be spread during sex

BACKGROUNDER CONTRACEPTION

Glossary. amenorrhea, primary - from the beginning and lifelong; menstruation never begins at puberty.

Achieving Independence. A Guide to Self-Catheterization with the Bard Touchless Plus Intermittent Catheter System

Leader's Resource. Note: Both men and women can have an STD without physical symptoms.

Disorders of the Vulva

CONTRACEPTION LONG-ACTING REVERSIBLE CONTRACEPTIVES LARCS

Gonorrhoea. Looking after your sexual health

SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS

Trichomonas vaginalis. Looking after your sexual health

F REQUENTLY A SKED Q UESTIONS. Birth Control. A: There are many methods of birth con- ents. Making decisions about birth

Emergency Contraceptive Pills

Oral sex. Looking after your sexual health

Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing

BIRTH CONTROL AND PROTECTION

Thrush and Bacterial vaginosis. Looking after your sexual health

Have a shower, rather than a bath to avoid exposing your genitals to the chemicals in your cleaning products for too long. Always empty your bladder

Chlamydia. Looking after your sexual health

Birth Control M E T H O D S

All methods of birth control are MUCH SAFER than being pregnant! If 100 women use each method for a year, how many of them get pregnant?

Accent on Health Obgyn, PC HERPES Frequently Asked Questions

condoms condoms male and fe male and female cond male and female condoms male and female male an male and female male and condoms

Sexuality after your Spinal Cord Injury

WOMENCARE A Healthy Woman is a Powerful Woman (407) Birth Control Pills

Yes, I know I have genital herpes:

Sexually Transmitted Infections (STIs) and the STI Clinic

THINKING AHEAD: Arrange transportation for field trip to local clinic (Session 18) Identify a teen in recovery as a guest speaker (Session 21)

Where to get services How to use this brochure Questions to ask These choices don t work These choices might work Emergency Contraceptive Pills

Birth Control Comparison Chart HORMONAL METHODS

provider directory of youth-friendly HEALTH CENTERS

What is HPV? Low-risk HPV types. High-risk HPV types

cancer cervical What women should know about and the human papilloma virus

Genital warts. Looking after your sexual health

Get the Facts on Teen Sexuality

Intrauterine Device (IUD) THE FACTS

Effective long-lasting strategy to prevent unintended pregnancy. The intrauterine system for contraception after abortion.

How to Deal with Rumors and Misconceptions about IUDs

Understanding Fertility

Understanding and Preventing Bladder Infections in Women

Please read these instructions carefully before using Poise* Bladder Supports

Frequently Asked Questions

Frequently Asked Questions

A guide for people with genital herpes

Post-Coital Hormonal Contraception Instructions for Use of Plan B, Plan B One-Step, Next Choice One Dose, My Way, Generic Levonorgestrel and Ella

2005 Global Sex Survey results

Module 4 Teenage Pregnancy, Sexually Transmitted Infections and HIV/AIDS

signs suggesting chlamydia:

New Brunswick Health Indicators

Infection caused by the transmission of Trichomonas vaginalis (T. vaginalis) during sexual contact in which body fluids are exchanged.

Basic Presentation HIV/AIDS. For Use by Students, Teachers and the Public Seeking Basic Information About HIV/AIDS

Urinary Tract Infections

Related TeensHealth Links

HPV and HPV Testing. Human Papilloma Virus (HPV) What are viruses? What is HPV?

MODULE 11: RTI, STI AND RELATIONSHIP WITH HIV

Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011

The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011

MECHANISM OF ACTION. Fertility Awareness-Based Methods. Victoria H. Jennings, PhD Marcos Arevalo, MD, MPH Deborah Kowal, MA, PA

Rhode Island Department of Health Division of Infectious Diseases and Epidemiology

Acute pelvic inflammatory disease: tests and treatment

patient education Fact Sheet PFS003: Hormone Therapy APRIL 2015

HIV/AIDS: General Information & Testing in the Emergency Department

Palm Beach Obstetrics & Gynecology, PA

URINARY CATHETER CARE

The challenge of herpes

Balanitis (change on the helmet of the penis) This is a change in the skin on the glans (helmet) of the penis. It is often caused by either:-

Location: Clinical Practice Manual

101 CMR: EXECUTIVE OFFICE OF HEALTH AND HUMAN SERVICES 101 CMR : FAMILY PLANNING SERVICES

Treatment of sexually transmitted and other genital infections

How can herpes simplex spread to an infant?

Sexually Transmitted Infections (STI) One Day Update

TOOLS, TRENDS AND NEW TECHNOLOGIES IN HIV PREVENTION

Anatomy and Physiology of Human Reproduction. Module 10a

100 Questions and answers about HiV/aids. Questions Answers. about HIV/AIDS. New York State Department of Health

Why it is Important to Talk with Young People about HIV and AIDS 2. Facts about HIV and AIDS 3. How to Get Started 7

Genital herpes. Looking after your sexual health

WOOD COUNTY SCHOOL OF PRACTICAL NURSING. Medical/Surgical Nursing: Reproductive

PATIENT URINARY CATHETER PASSPORT

Medical criteria for IUCD s Based on the WHO MEC (2004- Annexure 3) system a woman s eligibility for IUCD insertion falls in 4 categories. These categ

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

Female Reproductive System. Unit 8 Lesson 2 Continued

2. What muscle pulls the testis down into the scrotum during development?

TREATMENT OF STI CONTACTS

Let s Learn the Basics about Cervical Cancer

Stay Healthy at Any Age!

Human Papilloma Virus (HPV)

HIV -The Facts BLT 043

Safe & Unsafe. abortion

The link between cervical cancer and HPV (human papillomavirus)

Unit 3 REPRODUCTIVE SYSTEMS AND THE MENSTRUAL CYCLE

Chapter 101 MAINECARE BENEFITS MANUAL CHAPTER III

LOVE! Healthier me! Steps to a. Show Your. My top 3 goals for this year are 1 2.

PROCEDURE FOR CLEAN INTERMITTENT CATHETERIZATION MALE

STD. Teaching Outline and Resource Guide HEALTH AND WELLNESS

Transcription:

Women s Health Care Barrier Methods of Contraception Although abstinence remains the ultimate in barrier contraception, it is not always an acceptable option. To prevent unplanned pregnancies and the spread of sexually transmitted infections, physicians must have a strong knowledge of the different barrier contraceptives available. By Jacqueline Hurst, BSc, MD Worldwide, on a daily basis, there are 140 million acts of sexual intercourse. 1 The results of all this activity include 450,000 unplanned pregnancies (out of 950,000 conceptions), 356,000 infections and the release of an astronomical number of sperm. For many individuals, an appropriate contraceptive method needs to combine both contraception and protection from sexually transmitted infection (STI). In this article the author will discuss the effectiveness of barrier methods regarding: Protection against pregnancy quoted as a percentage of 100 women, and therefore couples, protected during one year of perfect use (Table 1 will also show typical use); 2 and The rate of genital STIs (syphilis, gonorrhea, HIV, chlamydia and trichomonas) and PID (pelvic inflammatory disease) in females, relative to chance. 3 This is not to suggest that STI rates and their sequelae in females male partners are unimportant however, there is a lack of data on this topic. 63

One might argue that abstinence is the best of the barriers 100% effective against pregnancy and STIs. If abstinence is not an option, then mechanical and chemical barriers are the next most effective methods for prevention of STIs and PID with the greatest reduction occuring when they are used in combination. Dr. Hurst is clinical instructor, faculty of medicine, University of British Columbia. Condoms Male condoms One of the oldest methods of birth and infection control is the male latex condom. If combined with spermicide (foam spreads the best) it is 99% effective against pregnancy. Without spermicide, it is 97% effective. The rate of STIs is decreased by 90%. 2 The rate of PID is reduced by 50%. Condoms containing spermicide do not provide any extra protection against STIs or pregnancy and may increase the chance of latex allergy, since the spermicide can cause an allergic protein to be released from the latex. 4 The male polyurethane condom, in combination with spermicide, is 97% effective against pregnancy. Recent studies suggest that this condom is more effective against STIs than latex. Natural (sheep) condoms are equally effective against pregnancy, but offer no protection against STIs. Female condom This polyurethane condom is 95% effective against pregnancy. In vitro studies suggest a decreased rate of STIs, including human papilloma virus (HPV) and herpes simplex virus (HSV), but no human studies have been completed as yet. As with the male polyurethane condom, it can be used with an oil-based (or water-based) lubricant (latex requires water-based as oil-based will disintegrate the rubber). The female condom comes with lubricant already applied to both the outer and inner portions. Extra lubricant, which is included in the package, can be added if required. 64

Table 1 Barrier methods of contraception Barrier Typical use Perfect use STI % PID % decrease Cost *** method effectiveness * effectiveness ** decrease relative relative to to chance ** chance ** Condom without 86% 97% 90% 50% $0.50 spermicide Condom 88% 99% 90% 50% $0.50 with vaginal plus cost of spermicide added spermicide Cap-nulliparous 80% 91% 50% 62% $40 Cap-multiparous 60% 74% 50% 62% $40 Lea s shield 91% 50% 62% $50 with spermicide Lea s shield 87% 50% 62% $50 without spermicide Diaphragm 80% 94% 50% 62% $40 Female condom 79% 95% no human studies no human studies $4 Sponge-parous 60% 80% no studies no studies $2.50 Sponge-nulliparous 80% 91% no studies no studies $2.50 Foam 74% 94% 50% excluding HIV 50% $18 (20-25 doses) Cream 74% 94% 50% excluding HIV 50% $20 Gel 74% 94% 50% excluding HIV 50% $20 Suppository 74% 94% 50% excluding HIV 50% $20 Film 74% 94% 50% excluding HIV 50% $2 Nonoxynyl 9 74% 94% 50% excluding HIV 50% $3 Withdrawal 81% 96% HIV 50% 0% $0 otherwise chance *Nelson AL, Hatcher RA, Zieman M, et al: Managing Contraception. Bridging the Gap Foundation, Tiger, Georgia, 2000. 2 **Trussell J, Koenig J, Stewart F, et al: Medical care cost savings from adolescent contraceptive use. Family Planning Perspectives 1997; 29(6):55. 3 ***Sex Sense: Canadian Contraception Guide. Society of Ob.and Gyn. of Canada, 2000. 7 HIV = Human immunodeficiency virus The female condom is inserted with the smaller ring over the cervix and the larger ring outside the vagina over the labia (thus the decrease in HPV, HSV potential). Insertion can be done anytime up to eight hours prior to intercourse. It should be removed before standing up after intercourse. Prospective users should be warned that, dur- 65

ing intercouse, the polyurethane movement can be noisy. In addition, users must make sure that the penis is inserted inside the condom and not around the outside edge. Cap, Lea s Shield and Diaphragm These methods, when used with either a gel or a cream spermicide (not foam as it disintegrates the rubber), have been shown to decrease the rate of STIs by 50% (excluding HIV) and of PID by 62%. They are thought to work by two methods: preventing pooling of sperm at the cervix, therefore decreasing the sperm s ability for capacitation (sperm outer membrane joined with the acrosome), and disruption of sperm by the spermicide. Cap The cap is made of latex and comes in four different sizes (22, 25, 28 and 31). Its effectiveness against pregnancy, with spermicide filling one third of the cap, is 91% in nulliparous women and 74% in multiparous women (i.e., they are two times as likely to fail in parous women, particularily during the first year of use, despite no significant user difference). The cap is not effective during menstruation, perhaps due to the pooling of fluids. The best fit results in the cap covering the entire cervix, right up to the fornices, and grabbing around the neck. For many women, a suitable size isn t available. The cap must be inserted at least 30 minutes prior to intercourse to allow for full suction (created by squeezing the end of the cap once it s on the cervix and turning it onequarter turn) and it must remain in place for at least eight hours post-intercourse. The cap provides protection for 24 hours without any further spermicide required, although adding more (into the vagina, not into the cap) may enhance effectiveness. The cap should be replaced every one to two years in spite of usage frequency. Odour can be a problem and is best solved by putting the cap in a solution of chlorophyll and water. Lea s Shield The Lea s shield is made of silicone (one size fits all) and is designed to sit in the posterior cul-de-sac and cover the cervix without actually resting on it. A one-way valve creates suction and also allows secretions to escape, thereby decreasing odour. Prior to insertion of the shield, the bowl should be filled about one-third full with spermicide. Although the shield provides protection for 48 hours, it should be removed within 24 hours to avoid toxic shock risk. Unlike the cap, this method 68

continues to work during menstruation, with an effectiveness rate of 91% against pregnancy, with the use of a spermicide, and 87% without. 5 The shield can be inserted at any time prior to intercourse, keeping in mind the 24-hour wear limit, and should be left in place at least eight hours post-intercourse. No additional spermicide is needed with repeat intercourse. If lubrication is required, a waterbased product should be used. The shield will turn yellow after approximately six months, in spite of washing it with soap and water. The valve area can be cleaned with a cotton swab. It should be replaced after six months. Diaphragm The diaphragm is composed of latex and a latex-covered steel ring and is available in four sizes (it used to be available in six sizes). It is inserted with the concave side facing the cervix. One tablespoon of spermicide should be placed in the concave side, either prior to insertion or with an applicator just after insertion (this latter method helps prevent spermicide getting on the labia). If more than three hours lapse prior to first intercourse after insertion, additional spermicide should be used. If intercourse is repeated, additional spermicide should be inserted in front of the diaphragm (i.e., on the convex side). If all of these instructions are followed, the diaphragm is 92% effective against pregnancy. As with the cap and Lea s shield, the diaphragm must be left in place for at least eight hours after intercourse and should be left in no longer than a total of 24 hours. This precaution is not only useful for preventing toxic shock, but also for preventing urinary tract infections (the rate of which increases, particularily in those with a prior history of UTIs) since the ring of the diaphragm pushes on the urethra. 6 The sponge The sponge combines a barrier method and spermicide in one product. It is made of polyurethane foam and its gel contains a combination of three spermicides (all lowdose so they are less irritating to the vagina): nonoxynol-9, benzalkonium chloride and sodium cholate. This method works by absorbing and trapping sperm (in the sponge itself) and destroying sperm (spermicide contained in the product). The sponge should be placed in the vagina at least 15 minutes prior to intercourse and provides protection for 12 hours (i.e., a new sponge is needed if intercouse is to be repeated after six hours, as the sponge must remain in place for at least six hours post-intercourse). There is some suggestion that the risk of toxic shock increases after 12 hours, therefore it shouldn t be inserted more than six hours prior to intercourse. 7 The sponge is 91% effective against pregnancy in nulliparas and 81% in multiparas. There are, as yet, no studies that the author is aware of regarding STI and PID prevention. Spermicides Available spermicides work by detergent action on sperm and, therefore, also irritate the vaginal wall. Although most STIs and PID are decreased by 50% with the use of spermicides, there is potential for an increased rate of HIV. Spermicides can cause vaginal epithelial changes and genital ulceration. 8 Since ulcerations are associated with an 69

increase in HIV transmission, frequent use of spermicide could leave the individual more vulnerable to HIV (and also bacterial vaginosis). Effectiveness against pregnancy has been reported as high as 94%, with a higher failure rate during the first six months of use. All spermicides should be inserted high into the vagina, hopefully over the cervix (where they will have a barrier effect as well as a detergent action). All spermicides need to be inserted at least five minutes prior to intercourse to allow for dispersal time. Spermicidal foam, cream, jelly, suppositories and tabs are made of two components; an inert base that ensures dispersion and holds the spermicidal agent in the vagina and a spermicidal chemical creams and gels contain 2% to 6% nonoxynol 9, foam 12%. Foam spreads more easily, thereby accounting for its increased effectiveness with condom usage (from both its percentage of nonoxynol 9 and spread). Foam will disintegrate rubber or silicone, in the long term, and can t be used with caps, diaphragms or Lea s shields. Creams, gels and foam remain effective for one hour when used solo, but longer when used inside a cap, diaphragm or shield. Vaginal contraceptive film contains 72 mg of nonoxynol 9 and comes in a 5-cm by 5-cm sheet. It is most easily inserted by folding it in half, then in half again. Bio-adhesive gel uses a bio-adhesive technology (with a low dose of nonoxynol 9 [3.5%] and some lubricant). It remains effective for 24 hours, but only for one act of intercourse (i.e., it must be replenished if intercourse occurs again). It comes in a disposable applicator, which holds the correct dose, and it should be applied at least 30 minutes prior to intercourse. Withdrawal A final method, and arguably not a real barrier method, is withdrawal. It has been included since the end result is an avoidance of egg-sperm togetherness. Withdrawal, or coitus interuptus, is 81% effective against pregnancy. It has recently been determined that the pre-ejaculate contains no sperm, but that a previous ejaculation can leave sperm hiding in the folds of the urethral lining. 2 Therefore, the male should urinate and wipe the tip of his penis to remove any of the remaining sperm prior to using withdrawal a second time. Ejaculation postwithdrawal must occur away from the introitus. Some studies suggest this method offers a 50% reduction D x in HIV infection from male to female. 9 References: 1. International Planned Parenthood Federation: Defining Key Issues for the Future. Forum 1994; Dec:30. 2. Nelson AL, Hatcher RA, Zieman M, et al: Managing Contraception. Bridging the Gap Foundation, Tiger, Georgia, 2000. 3. Trussell J, Koenig J, Stewart F, et al: Medical care cost savings from adolescent contraceptive use. Family Planning Perspectives 1997; 29(6):55. 4. Hatcher RA, Trussell J, Stewart F, et al: Contraceptive Technology. Seventeenth edition. Ardent Media Inc., New York, 1998. 5. Mauck C, Glover LH, Miller E, et al: Lea's shield: A study of the safety and efficacy of a new vaginal barrier contraceptive used with and without spermicide. Contraception 1996; 53:329-35. 6. Hooten TM, Scholes D, Hughes JP, et al: A prospective study of risk factors for symptoms of urinary tract infection in younger women. N Engl J Med 1996; 335(7):468-74. 7. Sex Sense: Canadian Contraception Guide. Society of Ob.and Gyn. of Canada, 2000. 8. Hurst J: The Misunderstood Condom. The Canadian Journal of Diagnosis 1999, 16(6):96-107. 9. Gervasoni C, Lazzarin A, Musicco M, et al: Contraceptive practices and man-to-woman HIV sexual transmission. VIII International Conference on AIDS. Amsterdam, July, 1992. 70